ARCHIVES

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

This article is from The Cancer Letter archive.

Vol. 14 No. 36 | September 2, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: Friedman Leads FDA During Search; Mead Retires From NCI; Freireich Honored

March 14, 1997

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

NCI Lists Projected Grant Paylines

February 16, 1996

Funding Opportunities: NKCA Offers Young Researcher Award

March 6, 1998

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

Two NCI Officials Leave for Industry, Academia: Carl Barrett Goes to Novartis, Karen Antman Named Provost and Dean at Boston University.

February 18, 2005